RAFAEL
CARRETERO COCA
PROFESOR AYUDANTE DOCTOR (LOSU)
Argitalpenak (27) RAFAEL CARRETERO COCA argitalpenak
2024
-
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer
Journal of Medicinal Chemistry, Vol. 67, Núm. 19, pp. 17429-17453
-
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models
Journal of Clinical Investigation, Vol. 134, Núm. 18
-
The Alliance Between the German Cancer Research Center and Bayer: A Retrospective of an Innovative Collaboration Model
Handbook of Experimental Pharmacology (Springer Science and Business Media Deutschland GmbH), pp. 83-95
2023
-
Secretogranin II influences the assembly and function of MHC class I in melanoma
Experimental Hematology and Oncology
-
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: A selective small molecule inhibitor for cancer immunotherapy
Journal for ImmunoTherapy of Cancer, Vol. 11, Núm. 11
2022
-
Rgs16 promotes antitumor CD8+ T cell exhaustion
Science Immunology, Vol. 7, Núm. 71
-
T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
OncoImmunology, Vol. 11, Núm. 1
2017
-
Basophils promote tumor rejection via chemotaxis and infiltration of CD8+ T cells
Cancer Research, Vol. 77, Núm. 2, pp. 291-302
2016
2015
-
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT
International Journal of Cancer, Vol. 136, Núm. 5, pp. E326-E339
-
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8 + T cells
Nature Immunology, Vol. 16, Núm. 6, pp. 609-617
-
Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
Oncotarget, Vol. 6, Núm. 7, pp. 4663-4676
2014
-
Involvement of HLA class i molecules in the immune escape of urologic tumors
Actas Urologicas Espanolas
2013
-
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis
Molecular and Cellular Proteomics, Vol. 12, Núm. 8, pp. 2111-2125
-
VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population
Human Immunology, Vol. 74, Núm. 1, pp. 98-103
2012
-
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer
Human Immunology, Vol. 73, Núm. 6, pp. 668-672
-
Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates
Human Gene Therapy Methods, Vol. 23, Núm. 5, pp. 285-296
-
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
International Journal of Cancer, Vol. 131, Núm. 2, pp. 387-395
2011
-
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846